The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. That said, here is one value stock offering a compelling risk-reward profile and two with little support.
Two Value Stocks to Sell:
Masco (MAS)
Forward P/E Ratio: 14.1x
Headquartered just outside of Detroit, MI, Masco (NYSE: MAS) designs and manufactures home-building products such as glass shower doors, decorative lighting, bathtubs, and faucets.
Why Should You Sell MAS?
- Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
- Earnings per share were flat over the last two years and fell short of the peer group average
- Eroding returns on capital suggest its historical profit centers are aging
Masco is trading at $62.22 per share, or 14.1x forward P/E. Read our free research report to see why you should think twice about including MAS in your portfolio.
Enovis (ENOV)
Forward P/E Ratio: 6.2x
With a focus on helping patients regain or maintain their natural motion, Enovis (NYSE: ENOV) develops and manufactures medical devices for orthopedic care, from injury prevention and pain management to joint replacement and rehabilitation.
Why Are We Out on ENOV?
- Annual sales declines of 6% for the past five years show its products and services struggled to connect with the market during this cycle
- Negative returns on capital show that some of its growth strategies have backfired, and its decreasing returns suggest its historical profit centers are aging
- Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned
Enovis’s stock price of $23.80 implies a valuation ratio of 6.2x forward P/E. If you’re considering ENOV for your portfolio, see our FREE research report to learn more.
One Value Stock to Watch:
Leidos (LDOS)
Forward P/E Ratio: 13x
Formed through the split of IT services company SAIC, Leidos (NYSE: LDOS) offers technology and engineering solutions such as military training systems for the defense, civil, and health markets.
Why Could LDOS Be a Winner?
- Sales pipeline is in good shape as its backlog averaged 20.2% growth over the past two years
- Operating profits and efficiency rose over the last five years as it benefited from some fixed cost leverage
- Share repurchases over the last two years enabled its annual earnings per share growth of 28.2% to outpace its revenue gains
At $160.84 per share, Leidos trades at 13x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
